The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Access · International · continued

Second pass at: Cross-border purchase within the EU: the actual rules posts 121–140

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

JI
j.iyerTL224 Mar 2025#121

Adding what did not work for me on Cross-border purchase within, since the failures never get written up and they are half the useful information.

30 likes 16mo
PM
physio_marchettiTL2Physiotherapist25 Mar 2025#122

Right, and stated more narrowly than I would have dared to state it.

15 likes 16mo
NO
n.oseiTL225 Mar 2025#123
a.kowalski, post #78: Building on post #76 rather than restating it. Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page. Go to post

The claim about Cross-border purchase within upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post says "causes".

3 likes in reply to #78 16mo
VS
v.szaboTL3Analytical chemist26 Mar 2025#124
lc_gradient, post #51: The most useful thing anyone can add to a thin regional thread is what the official source says and where it is, rather than what happened to them. I am reporting what happened, not recommending it. Go to post

Post #123 is the version of this I will quote in future. One addition.

Import rules for personal quantities are jurisdiction-specific and change without much publicity. Establishing your own position is unavoidable.

0 likes in reply to #51 16mo
HV
h.vargaTL226 Mar 2025 · edited#125

I would call the community position on Cross-border purchase within likely rather than established, and I would be comfortable defending that hedge.

23 likes 16mo
DO
d.oyelaranTL3Pharmacist27 Mar 2025#126

Customs practice varies between entry points within the same country, which is why two people in the same jurisdiction report different experiences honestly.

10 likes 16mo
CT
c.tullochTL227 Mar 2025#127
v.kjaer, post #67: Taking post #66 at face value and following it one step further. The confident answers on Cross-border purchase within and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category. Go to post

Post #123 put the caveat in the right place and I want to underline it.

What I can speak to on Cross-border purchase within is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.

1 like in reply to #67 16mo
K
KLindqvistTL4 Moderator28 Mar 2025#128

Building on post #127 rather than restating it.

Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.

The interesting part of this is the exception, and I do not understand the exception.

0 likes 16mo
PK
p.krastevTL228 Mar 2025#129

On post #127 — agreed on the reasoning, with one qualification.

My understanding of Cross-border purchase within is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.

16 likes 16mo
RV
r.venkatesanTL3Wiki editor28 Mar 2025#130

Picking up post #127: that is the part I would want checked first.

Summaries lag badly in this area. Where a decision matters, read the current official document rather than a page about it, including this one.

6 likes 16mo
K
KTurkingtonTL3Regular29 Mar 2025#131

Post #130 answers the question as asked. The question underneath it is different.

Reading this Cross-border purchase within thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.

9 likes 16mo
TD
t.demirTL229 Mar 2025#132

I read post #128 twice before replying, because I had assumed the opposite.

Cross-border prescribing and cross-border dispensing are different questions with different answers in most jurisdictions.

I would put this at better than even and not much better.

21 likes 16mo
TN
t.ndiayeTL230 Mar 2025#133
s.poulsen, post #115: Customs practice varies between entry points within the same country, which is why two people in the same jurisdiction report different experiences honestly. Go to post

Nothing here is legal advice, and in this subcategory that caveat is doing real work rather than sitting decoratively at the end.

It is the kind of thing that is obvious once and never again.

0 likes in reply to #115 16mo
AF
a.friskTL230 Mar 2025#134

Filing a mild objection to the consensus on Cross-border purchase within. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.

2 likes 16mo
NB
n.bridgewaterTL2Member31 Mar 2025#135

Whatever the answer on Cross-border purchase within turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.

14 likes 16mo
AN
a.norgaardTL231 Mar 2025#136
owen.brady, post #87: Confirming post #85 from a second method, which matters more than confirming it from a second person. Posting my Cross-border purchase within numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a particular answer. Go to post

Good question, well framed, and I would like to see it answered properly.

28 likes in reply to #87 16mo
TI
trough_indexTL3Regular1 Apr 2025#137

Taking post #134 at face value and following it one step further.

Where a compound is approved under a different trade name in another market, searching the local name finds documents the English name does not.

Adding this to the thread rather than to the wiki, because I am not confident enough for the wiki.

8 likes 16mo
EM
e.mwangiTL21 Apr 2025 · edited#138

Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union; tirzepatide approved in some but not all; retatrutide approved nowhere yet (ongoing trials).

The general answer and the answer for your case may diverge here.

5 likes 16mo
MB
m.brobergTL21 Apr 2025#139

On Cross-border purchase within the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.

0 likes 16mo
SL
s.leclercTL4 Moderator2 Apr 2025#140
m.ivaturi, post #46: I changed my mind about Cross-border purchase within after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it happens. Go to post

The practical version of Cross-border purchase within is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.

2 likes in reply to #46 16mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Prescription portability between countries — the long version
On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. A narrow question about Prescription portability between countries,…
HVMRSC 2 182 21h
Travelling with an injectable: documentation and practicalities
Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting a stated criterion rather than an outcome,…
CHATJSFEB+37 42 2.1k 1d
Personal import allowances, compared
On the subject in the title: Personal import allowances, compared Working notes rather than a conclusion. I have spent a fortnight trying to pin personal import allowances down and I want to set out where I…
BANNKAKSC+5 9 3.2k 7mo
Prescription portability between countries
Prescription portability between countries — setting out what I have, and where I think it stops being reliable. Asking about prescription portability between countries directly, because I have read four…
SGTLDCIAL+104 114 6.1k 3h
Revisiting: Language barriers in accessing a prescription abroad
Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Asking about Language barriers in accessing on behalf of…
MMLSSLMIMH+131 148 28k 5mo

Related topics — sharing the tags NHS, personal import, EMA

TopicParticipantsRepliesViewsActivity
MHRA statements, read directly — the long version
On the subject in the title: MHRA statements, read directly — the long version Working notes rather than a conclusion. Asking about MHRA statements directly, because I have read four threads on it and each…
BRTDSL 2 44k 22mo
EU-wide position versus national implementation — what changed since
EU-wide position versus national implementation — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of eu-wide position…
NMATTPBI+22 26 58k 2mo
Reimbursement variation across member states
Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. Asking about reimbursement variation across member states directly, because I…
SFJSREBS+7 11 39k 3mo
Travelling with an injectable: documentation and practicalities
Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting a stated criterion rather than an outcome,…
CHATJSFEB+37 42 2.1k 1d
Second pass at: Pharmacy supply in the UK and the questions you will be asked
Second pass at: Pharmacy supply in the UK and the questions you will be asked Writing it up because I had to work it out twice and would rather nobody else did. Asking about Pharmacy supply on behalf of the…
DBDATFHKD+46 53 14k 12mo